fr 66973 has been researched along with Leukemia L 1210 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Masuda, K; Nakamura, T; Shimomura, K | 1 |
| Manda, T; Masuda, K; Matsumoto, S; Mori, J; Nakamura, T; Oku, T; Shimomura, K | 1 |
| Masuda, K; Mizota, T; Mori, J; Nakamura, T; Shimomura, K | 1 |
3 other study(ies) available for fr 66973 and Leukemia L 1210
| Article | Year |
|---|---|
Specific metabolic activation of FK973, a new antitumor antibiotic, in L1210 leukemia cells.
Topics: Animals; Antibiotics, Antineoplastic; Benzylamines; Biotransformation; Cell Survival; DNA, Neoplasm; Iproniazid; Leukemia L1210; Mice; Monoamine Oxidase; Organoplatinum Compounds; Oxazines; Tranylcypromine; Tumor Cells, Cultured | 1990 |
Effect of FK973, a new antitumor antibiotic, on the cell cycle of L1210 cells in vitro.
Topics: Animals; Antineoplastic Agents; Bromodeoxyuridine; Cell Division; Cytarabine; DNA, Neoplasm; Flow Cytometry; Leukemia L1210; Mitomycin; Mitomycins; Mitosis; Oxazines; Time Factors; Vinblastine | 1989 |
Interstrand DNA-DNA and DNA-protein cross-links by a new antitumor antibiotic, FK973, in L1210 cells.
Topics: Animals; Antibiotics, Antineoplastic; Cell Survival; DNA; Hydrogen-Ion Concentration; Leukemia L1210; Macromolecular Substances; Mice; Nucleic Acid Conformation; Oxazines | 1988 |